Spain's Financial Crisis Sinks Stocks
Concerns about Spain's financial crisis sent the markets tumbling to a sharply lower close with the Dow sinking 120 points to 12,822. Nasdaq plummeted 40 points to 2925.
On the upside
The Food and Drug Administration approved Onyx Pharmaceuticals' (NYSE: ONXX) multiple myeloma treatment Kyprolis.
StemCells (Nasdaq: STEM) advanced again after reporting positive results from an Alzheimer's disease study on Tuesday.
The European Medicines Agency's Committee for Medical Products for Human Use recommended approval for Astex Pharmaceuticals' (Nasdaq: ASTX) secondary acute myeloid leukemia treatment Dacogen.
On the downside
Xerox (NYSE: XRX) reported lower second quarter earnings and revenue and cut its earnings guidance for the full year.
A surge in borrowing costs for Spain weighed down shares of Banco Bilbao (NYSE: BBVA).
Rambus (Nasdaq: RMBS) widened second quarter losses as revenue fell.
In the broad market, declining issues outpaced advancers by a margin of 2 to 1 on the NYSE and by nearly 3 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks plummeted 10 points to 791.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here